Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Androctonus australis hector (Aah) venom neurotoxins are a group of highly potent peptides produced by the North African fat-tailed scorpion, which are responsible for severe and often fatal envenomation in humans (PubMed: 11518353). These toxins primarily target voltage-gated sodium (Nav) channels, with the most lethal component, Aah II, acting as an alpha-toxin that binds to receptor site 3 (UniProt: P01484). By binding to this site, the toxins inhibit the inactivation of the sodium channel, leading to prolonged action potentials and a massive release of neurotransmitters, which triggers a life-threatening autonomic storm (PubMed: 10657230). Clinical manifestations include hypertension, pulmonary edema, and cardiovascular collapse, making these toxins a major public health concern in endemic regions (PubMed: 15649515). While they are not therapeutic targets in the traditional sense, they are the primary focus for the development of antivenoms and serve as essential pharmacological tools for studying ion channel physiology (PubMed: 12126521).
The neurotoxins bind to specific sites on voltage-gated sodium channels; alpha-toxins bind to site 3 to inhibit inactivation, while beta-toxins bind to site 4 to shift the voltage-dependence of activation, both leading to prolonged depolarization and repetitive firing of neurons (PubMed: 10657230).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Androctonus australis hector venom neurotoxins (Aah toxins).